Tipepidine as adjuvant therapt in major depressio

Phase 3

Recruiting

• Conditions: Major Depressive Disorder.; Major depressive disorder, single episode, moderate; F32.1

• Registration Number: IRCT20090117001556N122
• Lead Sponsor: Tehran University of Medical Sciences,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Presence of Major Depressive Disorder based on DSM-5 criteria
Baseline Hamilton Depression Rating Scale (HAM-D) (17-item) score of at least 19

Exclusion Criteria

Presence of psychosis
Any other mental disorder
Hypothyroidism
Cardiovascular disease
Pregnancy or nursing women
receiving ECT during last two months
substance use
receiving any other psychotropic medications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of depression. Timepoint: Baseline and weeks 2,4 and 6. Method of measurement: by Hamiltion Depression Rating Scale 17-Item.